Clinical Trial for Advanced Bile Duct Cancer
0 Mga view
• 07/01/23
0
0
I-embed
administrator
Mga subscriber
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento